MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive gain
-$25,196K
(37.72%↑ Y/Y)
Net gain
-$25,196K
(37.72%↑ Y/Y)
Other income, net
$1,183K
(10.35%↑ Y/Y)
Product
$43,391K
Collaboration Revenue
$36,713K
Interest expense
$19,798K
(1.89%↑ Y/Y)
Loss from operations
-$6,581K
(70.22%↑ Y/Y)
Total revenues
$80,104K
(23.25%↑ Y/Y)
Total operating
expenses
$86,685K
(-0.47%↓ Y/Y)
Selling, general and
administrative
$43,124K
(0.30%↑ Y/Y)
Cost of goods sold
$34,573K
(9.62%↑ Y/Y)
Research and development
$8,988K
(-28.42%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)